by admin | Nov 27, 2018 | Cognition Therapeutic, News
Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative disorders, today announced the addition of three renowned leaders in imaging and molecular biomarkers to the...
by admin | Nov 8, 2018 | Cognition Therapeutic, News
Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on synaptic protection and restoration in Alzheimer’s disease and other neurodegenerative disorders, today announced that patient treatment has begun in the Phase 2 SHINE study of Elayta™...
by admin | Oct 24, 2018 | Cognition Therapeutic, News
Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on synaptic protection and restoration in Alzheimer’s disease and other neurodegenerative disorders, today announced its sponsorship of the Third International Symposium on Sigma-2 Receptors:...
by admin | Oct 2, 2018 | Cognition Therapeutic, News
Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on synaptic health and restoration in Alzheimer’s disease and other neurodegenerative disorders, today announced that the National Institute on Aging (NIA) of the National Institutes of Health...
by admin | Sep 27, 2018 | Cariloop, News
Michael Walsh, Cariloop’s CEO and Co-Founder, has been selected as a finalist for the 2018 D CEO’s Excellence in Healthcare Awards. Walsh has been nominated for the Achievement in Medical Devices/Technology. Read More GrowCo Capital817-769-6900133 Nursery LaneFort...
by admin | Sep 26, 2018 | Cariloop, News
HR Dive speaks to HR leaders and Benefits Specialists around the world on why it doesn’t matter what your workforce looks like, you have employee caregivers who need help. This article features Cariloop’s CEO, Michael Walsh, discussing the importance of supporting...
